ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Holders of 5% or more of ADCT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ADC Therapeutics SA, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Redmile Group, LLC | 13G/A | 14.00%15.7M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| HPWH TH AG | 13G/A | 9.61%9.79M shares | – | May 19, 20251 filing | May 19, 2025 | SEC |
| Point72 Asset Management, L.P. | 13G | 7.00%7.83M shares | New | Jun 17, 20251 filing | Jun 17, 2025 | SEC |
| Prosight Management, LP | 13G/A | 5.80%7.20M shares | – | Nov 13, 20251 filing | Nov 13, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 5.00%4.91M shares | −0.20 ppfrom 5.20% | Feb 3, 20252 filings | Apr 24, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on ADC Therapeutics SA, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 20257:38 PM ET | Prosight Management, LPand 4 others | 13G/A | 5.80%7.20M shares | – | Sep 30, 2025 | SEC |
| Nov 5, 20254:05 PM ET | Oaktree Capital Group Holdings GP, LLCand 6 others | 13G/A | 4.14%4.67M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20254:15 PM ET | Redmile Group, LLCand 2 others | 13G/A | 14.00%15.7M shares | – | Jun 30, 2025 | SEC |
| Jun 17, 20255:28 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 7.00%7.83M shares | New | Jun 16, 2025 | SEC |
| May 19, 20257:40 PM ET | HPWH TH AGand 2 others | 13G/A | 9.61%9.79M shares | – | May 15, 2025 | SEC |
| Apr 24, 202510:50 AM ET | BlackRock, Inc. | 13G/A | 5.00%4.91M shares | −0.20 ppfrom 5.20% | Mar 31, 2025 | SEC |
| Feb 14, 20254:35 PM ET | OrbiMed Advisors LLCand 1 other | 13G | 3.60%3.44M shares | NewBelow 5% | Dec 31, 2024 | SEC |
| Feb 3, 20256:10 PM ET | BlackRock, Inc. | 13G | 5.20%5.01M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ADC Therapeutics SA shares.
No Form 144 notices for ADC Therapeutics SA are on file.